Group leader

macular-banner [F]oxymoron Angelo Juan Ramos David Rouhani Lori Greig Pete Fang Guo Ryan Kitko cursedthing GoRun26 @ Flikr David Rouhani

The Macular Research Group (formerly known as the Retinal Therapeutics Research Unit) is based at the Save Sight Institute on the campus of the Sydney Eye Hospital. Our mission is to develop new treatments that will reduce the prevalence of blindness from macular disease, through multidisciplinary, patient oriented, world class research. The group is headed by Professor Mark Gillies and is made up of two cohesive research units -

Overview Overview Aim
Current & Upcoming Trials Projects Collaboration
-Macular Degeneration   -Studies on Müller glia-neuron and vascular interactions using inducible and Müller cell-specific gene targeting mice Background
 -Cystoid Macular Oedema   -Metabolic dysfunction and Retinal Diseases Key Activities
     -Diabetic Retinopathy   -The distinct roles of Müller cells in central and peripheral human retina Progress
     -Diabetic Macular Oedema   -The Role of TLR-mediated Neuroinflammation in Retinal Disease Outcomes
    -Branch Retinal Vein Occlusion  -Differential expression of microRNAs in a murine model of selective Müller cell ablation FRB! Video
    -Central Retinal Vein Occlusion  -The contribution of aberrant Wnt signaling to neuronal and vascular pathology in retinal disease Publications
  -Macular Telangiectasia   -Dysregulation of interphotoreceptor retinoid binding protein in the pathogenesis of retinal disease  
Make an Appointment   -Use patient-derived stem cells to treat and model macular diseases  
Refer a Patient  Recent Publications  
Receive Trial Updates  Find Us  
Publications   Contact Us  
Find Our Clinics    
Contact Us    

Our Staff